NEW YORK, May. 1 - Incyte Genomics today posted a wider first-quarter loss and blamed falling subscription and licensing revenue.

Revenue fell to $29 million from $51 million after the firm discontinued its custom genomic product lines last October, the company said.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.